SNTI

Senti Biosciences Holdings, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.15

Price (1 Year)

$2.23 $0.15

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %13.3 / %30
Non-compliant assets / Total market cap %21.7 / %30
Non-compliant revenue / Total income %92.8 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need.

Website

Analysis (Turkish): SNTI Hissesi Caiz mi, Helal mi? Senti Biosciences Holdings, Inc. Katılım Analizi